Funding for this research was provided by:
Sunovion
Article History
Received: 19 April 2021
Accepted: 16 September 2021
First Online: 7 October 2021
Competing interests
: D.T. has served as a consultant and speaker for Sunovion, AstraZeneca, Innoviva/Theravance, Mylan, and Boehringer-Ingelheim. X.N., S.Sa., and S.Sh. are employees of Sunovion Pharmaceuticals Inc.